S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in

ASX:MVP - Medical Developments International Stock Price, Forecast & News

-0.10 (-1.08 %)
(As of 01/20/2020 10:46 AM ET)
Today's Range
Now: A$9.19
50-Day Range
MA: A$7.92
52-Week Range
Now: A$9.19
Volume73,587 shs
Average VolumeN/A
Market Capitalization$602.93 million
P/E Ratio574.38
Dividend Yield0.46%
Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment in Australia and internationally. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians. Medical Developments International Limited is headquartered in Scoresby, Australia.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Phone61 3 9547 1888



Sales & Book Value

Annual Sales$20.88 million
Cash FlowA$0.40 per share
Book ValueA$0.68 per share



Market Cap$602.93 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MVP News and Ratings via Email

Sign-up to receive the latest news and ratings for MVP and its competitors with MarketBeat's FREE daily newsletter.


Each week, an exclusive group of investors receives access to a simple list of 3 stocks to put on their radar for the week ahead.

You can sign up today to receive access to next week's watchlist -- generated by a proprietary methodology -- at no cost or obligation.

Medical Developments International (ASX:MVP) Frequently Asked Questions

What is Medical Developments International's stock symbol?

Medical Developments International trades on the ASX under the ticker symbol "MVP."

How often does Medical Developments International pay dividends? What is the dividend yield for Medical Developments International?

Medical Developments International declared a Final dividend on Thursday, August 22nd. Shareholders of record on Friday, October 4th will be paid a dividend of 0.02 per share on Friday, October 4th. This represents a yield of 0.42%. The ex-dividend date of this dividend is Tuesday, September 3rd. View Medical Developments International's Dividend History.

Has Medical Developments International been receiving favorable news coverage?

News stories about MVP stock have trended positive recently, according to InfoTrie. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medical Developments International earned a coverage optimism score of 3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Medical Developments International.

Who are some of Medical Developments International's key competitors?

What other stocks do shareholders of Medical Developments International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Developments International investors own include Elixinol Global (ELLXF), Talon Petroleum (TPD), Gold Road Resources (GOR), Core Lithium (CXO) and Bubs Australia (BUB).

Who are Medical Developments International's key executives?

Medical Developments International's management team includes the folowing people:
  • Mr. John Stewart Sharman, Chief Exec. Officer (Age 53)
  • Mr. Mark Edwards, CFO & Company Sec.
  • Dr. Scott Courtney, Director of Research & Operations
  • Michelle Bradney, Head of Medical Affairs
  • Wai Ng Chi, Head of Regulatory Affairs

What is Medical Developments International's stock price today?

One share of MVP stock can currently be purchased for approximately A$9.19.

How big of a company is Medical Developments International?

Medical Developments International has a market capitalization of $602.93 million and generates $20.88 million in revenue each year. Medical Developments International employs 55 workers across the globe.View Additional Information About Medical Developments International.

What is Medical Developments International's official website?

The official website for Medical Developments International is http://www.medicaldev.com/.

How can I contact Medical Developments International?

The company can be reached via phone at 61 3 9547 1888.

MarketBeat Community Rating for Medical Developments International (ASX MVP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  10 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  20
MarketBeat's community ratings are surveys of what our community members think about Medical Developments International and other stocks. Vote "Outperform" if you believe MVP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MVP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Featured Article: Inverted Yield Curve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel